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In the early nineteenth century, the ﬁrst recorded cholera out-
breaks occurred in South-East Asia,with theﬁrst six pandemics and
the seventh ongoing cholera pandemic.
After the major outbreaks of the mid-nineteenth century,
cholera was completely eliminated in Europe.
In Africa however signiﬁcant cholera outbreaks have only been
reported since 1970, and ifwe consider the cases reported byWHO,
it one of the most affected regions of the world.
Cholera remains one of the most important public health issues
in theDemocraticRepublic of Congo (DRC). Since1977, a succession
of outbreaks has occurred, seemingly without spatial or temporal
logic. The change of the 1970-1990’s epidemic proﬁle to the current
endemic proﬁle is in contrast with the dispersion, with no clear
logic and weak operational strategies.
An extensive research project has been conducted since 2005
in order to better understand the spatial and temporal dynam-
ics of cholera in the DRC and suggest adjustments to operational
strategies. The objective of this study has been to emphasize mul-
tidisciplinary approaches and to analyze the series of cholera cases
over the long-term.
The study showed evidence of the persistence and recurrence
of cholera epidemics during the dry season around the small lakes
areas. These cholera ‘sanctuaries areas’ were identiﬁed through the
detection of the seasonality of epidemics around the lake areas. The
evidence suggests that targeting the ‘sanctuaries areas’ located in
the African Great Lake Region should be a priority in the cholera
elimination plan in the DRC.
Based on the results and the recommendations of this work, the
DRC has adopted the 2013-2017 Multisectorial Plan to Eliminate
Cholera as a public health issue.
Using epidemiological monitoring combined with an under-
standing of the dynamics of the disease to complete the adjustment
of operational approaches shouldmotivate other countries inAfrica
where cholera remains a real public health issue.
The elimination of cholera in Africa is possible. But in order
for this to occur, cholera should be moved out of the perpetual
emergency reaction cycle. Local actors need to be empowered and
the international community has to agree to join and support that
objective.
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The emergence of a novel human coronavirus, ﬁrst reported
fromSaudi Arabia in September 2012, recently renamed theMiddle
East Respiratory Syndrome Coronavirus (MERS-CoV) has created
global alarm because it is the causative agent of a severe and fre-
quently fatal acute respiratory illness (SARI) resembling the illness
caused by severe acute respiratory syndrome (SARS) coronavirus
(SARS-CoV). All cases either occurred in the Middle East or had
direct links to a primary case infected in theMiddle East.MERS-CoV
can cause sporadic infection, infection among families, and, of par-
ticular concern, infection among healthcareworkers.Most patients
whowere initially infectedwithMERS-CoV had underlying comor-
bid medical conditions and laboratory testing showed that most of
these cases had raised concentrations of lactate dehydrogenase and
aspartate aminotransferase associatedwith thrombocytopenia and
lymphopenia.The case fatality rate (CFR) in patients infected with
MERS-CoV is high—estimated at 43% in 176 patients reported so far
by World Health Organization (WHO). This rate is higher than that
of SARS—estimated at 10%, and is strongly age- and sex-dependent.
Although the source of virus in patients with sporadic infection
remains unknown, although bats and camels have been implicated.
Clear evidence of limited human-to-human transmission of MERS-
CoV has now been documented in several case clusters, including
particularly family members and patients in health care facilities,
but all such clusters have, at least thus far, been limited in extent.
However, a real concern persists that the virus will adapt to inter-
human transmission and switch from an aborted epidemic to a
pandemic similar to the SARS-CoV epidemic in 2003–2004. MERS-
CoV is transmitted through droplets and contact. In the case of
invasive respiratory procedures, MERS-CoV is transmitted through
airborne route. Early diagnosis and strict implementation of the
core components for infection prevention and control programs
are crucial for preventing epidemic ampliﬁcation.
The emergence of respiratory viruses that cause signiﬁcant
disease in human beings is a major risk to the global economy
and the health of the human population. The potential effect
of newly discovered viruses calls for a better understanding of
the human–animal interface, the development of rapid diagnos-
tic tests, and effective antiviral and immunomodulatory therapies.
In the absence of an effective vaccine and a speciﬁc antiviral
treatment, there is an urgent need to rapidly identify potential
therapeutics.
http://dx.doi.org/10.1016/j.ijid.2014.03.573
